LOS ANGELES CAPITAL MANAGEMENT LLC - NATURAL GROCERS BY VITAMIN C ownership

NATURAL GROCERS BY VITAMIN C's ticker is NGVC and the CUSIP is 63888U108. A total of 95 filers reported holding NATURAL GROCERS BY VITAMIN C in Q2 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of NATURAL GROCERS BY VITAMIN C
ValueSharesWeighting
Q3 2023$858,786
-13.4%
66,521
-17.8%
0.00%0.0%
Q2 2023$992,214
+38.8%
80,931
+33.0%
0.00%
+33.3%
Q1 2023$714,988
+26.3%
60,850
-1.8%
0.00%0.0%
Q4 2022$566,232
-14.7%
61,951
+0.7%
0.00%0.0%
Q3 2022$664,000
-32.3%
61,5110.0%0.00%
-40.0%
Q2 2022$981,000
-21.0%
61,511
-2.8%
0.01%0.0%
Q1 2022$1,241,000
+37.6%
63,3110.0%0.01%
+66.7%
Q4 2021$902,000
-5.8%
63,311
-25.9%
0.00%
-25.0%
Q3 2021$958,000
-11.8%
85,425
-15.5%
0.00%
-20.0%
Q2 2021$1,086,000
-42.1%
101,107
-5.4%
0.01%
-37.5%
Q1 2021$1,875,000
+24.9%
106,827
-2.2%
0.01%
+33.3%
Q4 2020$1,501,000
+36.8%
109,217
-1.8%
0.01%
+20.0%
Q3 2020$1,097,000
-30.0%
111,227
+5.5%
0.01%
-37.5%
Q2 2020$1,568,000
+393.1%
105,400
+182.2%
0.01%
+300.0%
Q1 2020$318,000
-0.6%
37,350
+15.3%
0.00%0.0%
Q4 2019$320,000
-29.5%
32,405
-28.7%
0.00%0.0%
Q3 2019$454,000
+131.6%
45,430
+132.9%
0.00%
+100.0%
Q2 2019$196,000
+31.5%
19,510
+56.2%
0.00%0.0%
Q4 2016$149,000
+7.2%
12,4900.0%0.00%0.0%
Q3 2016$139,00012,4900.00%
Other shareholders
NATURAL GROCERS BY VITAMIN C shareholders Q2 2023
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 10,860$231,0005.74%
WALL STREET ASSOCIATES 124,900$2,657,0001.10%
Summit Creek Advisors LLC 294,125$6,256,0000.98%
MONTAGE INVESTMENTS, LLC 39,865$848,0000.60%
OUTFITTER ADVISORS, LTD. 41,815$889,0000.35%
FRONTIER CAPITAL MANAGEMENT CO LLC 1,055,744$22,456,0000.18%
GW&K Investment Management, LLC 339,151$7,214,0000.16%
RICE HALL JAMES & ASSOCIATES, LLC 93,288$1,984,0000.12%
Convergence Investment Partners, LLC 21,756$463,0000.06%
Granahan Investment Management 66,250$1,409,0000.05%
View complete list of NATURAL GROCERS BY VITAMIN C shareholders